|
OGEN | Oragenics Inc |
|
|
OGEN | Oragenics Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 4.19 |
| Leverage | 22.62% |
| Market Cap | $ 2.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -10.9m |
| Margin | 1514.17% |
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.